RESUMO
Thymic imaging is challenging because the imaging appearance of a variety of benign and malignant thymic conditions are similar. CT is the most commonly used modality for mediastinal imaging, while MRI and fluorine 18 fluorodeoxyglucose (FDG) PET/CT are helpful when they are tailored to the correct indication. Each of these imaging modalities has limitations and technical pitfalls that may lead to an incorrect diagnosis and mismanagement. CT may not be sufficient for the characterization of cystic thymic processes and differentiation between thymic hyperplasia and thymic tumors. MRI can be used to overcome these limitations but is subject to other potential pitfalls such as an equivocal decrease in signal intensity at chemical shift imaging, size limitations, unusual signal intensity for cysts, subtraction artifacts, pseudonodularity on T2-weighted MR images, early imaging misinterpretation, flow and spatial resolution issues hampering assessment of local invasion, and the overlap of apparent diffusion coefficients between malignant and benign thymic entities. FDG PET/CT is not routinely indicated due to some overlap in FDG uptake between thymomas and benign thymic processes. However, it is useful for staging and follow-up of aggressive tumors (eg, thymic carcinoma), particularly for detection of occult metastatic disease. Pitfalls in imaging after treatment of thymic malignancies relate to technical challenges such as postthymectomy sternotomy streak metal artifacts, differentiation of postsurgical thymic bed changes from tumor recurrence, or human error with typical "blind spots" for identification of metastatic disease. Understanding these pitfalls enables appropriate selection of imaging modalities, improves diagnostic accuracy, and guides patient treatment. ©RSNA, 2024 Test Your Knowledge questions for this article are available in the supplemental material.
Assuntos
Timoma , Neoplasias do Timo , Humanos , Fluordesoxiglucose F18 , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Recidiva Local de Neoplasia , Neoplasias do Timo/diagnóstico por imagem , Neoplasias do Timo/patologia , Timoma/diagnóstico , Tomografia por Emissão de Pósitrons , Imageamento por Ressonância Magnética , Compostos RadiofarmacêuticosRESUMO
Editor's Note.-RadioGraphics Update articles supplement or update information found in full-length articles previously published in RadioGraphics. These updates, written by at least one author of the previous article, provide a brief synopsis that emphasizes important new information such as technological advances, revised imaging protocols, new clinical guidelines involving imaging, or updated classification schemes.
Assuntos
Estadiamento de Neoplasias , Neoplasias Epiteliais e Glandulares , Neoplasias do Timo , Humanos , Neoplasias do Timo/diagnóstico por imagem , Neoplasias do Timo/patologia , Neoplasias Epiteliais e Glandulares/diagnóstico por imagem , Neoplasias Epiteliais e Glandulares/patologiaRESUMO
OBJECTIVE: This study aimed to evaluate the reliability of liver and spleen Hounsfield units (HU) measurements in reduced radiation computed tomography (RRCT) of the chest within the sub-millisievert range. METHODS: We performed a prospective, institutional review board-approved study of accrued patients who underwent unenhanced normal-dose chest CT (NDCT) and with an average radiation dose of less than 5% of NDCT. In-house artificial intelligence-based denoising methods produced 2 denoised RRCT (dRRCT) series. Hepatic and splenic attenuations were measured on all 4 series: NDCT, RRCT, dRRCT1, and dRRCT2. Statistical analyses assessed the differences between the HU measurements of the liver and spleen in RRCTs and NDCT. As a test case, we assessed the performance of RRCTs for fatty liver detection, considering NDCT to be the reference standard. RESULTS: Wilcoxon test compared liver and spleen attenuation in the 72 patients included in our cohort. The liver attenuation in NDCT (median, 59.38 HU; interquartile range, 55.00-66.06 HU) was significantly different from the attenuation in RRCT, dRRCT1, and dRRCT2 (median, 63.63, 42.00, and 33.67 HU; interquartile range, 56.19-67.19, 37.33-45.83, and 30.33-38.50 HU, respectively), all with a P value <0.01. Six patients (8.3%) were considered to have fatty liver on NDCT. The specificity, sensitivity, and accuracy of fatty liver detection by RRCT were greater than 98.5%, 50%, and 94.3%, respectively. CONCLUSIONS: Attenuation measurements were significantly different between NDCT and RRCTs, but may still have diagnostic value in appreciating hepatosteastosis. Abdominal organ attenuation on RRCT protocols may differ from attenuation on NDCT and should be validated when new low-dose protocols are used.
Assuntos
Inteligência Artificial , Fígado Gorduroso , Humanos , Estudos Prospectivos , Reprodutibilidade dos Testes , Estudos Retrospectivos , Tomografia Computadorizada por Raios X/métodosAssuntos
Compressão da Medula Espinal , Neoplasias da Coluna Vertebral , Humanos , Compressão da Medula Espinal/diagnóstico por imagem , Compressão da Medula Espinal/etiologia , Tomografia Computadorizada por Raios X , Imageamento por Ressonância Magnética , Neoplasias da Coluna Vertebral/diagnóstico por imagem , Neoplasias da Coluna Vertebral/secundárioRESUMO
Staging classification is essential in cancer management and is based on three components: tumor extent (T), lymph node involvement (N), and distant metastatic disease (M). For thymic epithelial malignancies, clinical Tumour, Node, Metastasis (cTNM) staging is primarily determined by imaging, making radiologists integral to clinical practice, treatment decisions, and maintaining the quality of staging databases. The ninth edition of the TNM classification for thymic epithelial tumors will be implemented in January 2025. This review outlines the definitions for the TNM categories in the updated edition, provides examples, and elaborates on the radiologist's role and imaging considerations.
RESUMO
PURPOSE: High volumes of chest radiographs (CXR) remain uninterpreted due to severe shortage of radiologists. These CXRs may be informally reported by non-radiologist physicians, or not reviewed at all. Artificial intelligence (AI) software can aid lung nodule detection. Our aim was to assess evaluation and management by non-radiologists of uninterpreted CXRs with AI detected nodules, compared to retrospective radiology reports. MATERIALS AND METHODS: AI detected nodules on uninterpreted CXRs of adults, performed 30/6/2022-31/1/2023, were evaluated. Excluded were patients with known active malignancy and duplicate CXRs of the same patient. The electronic medical records (EMR) were reviewed, and the clinicians' notes on the CXR and AI detected nodule were documented. Dedicated thoracic radiologists retrospectively interpreted all CXRs, and similarly to the clinicians, they had access to the AI findings, prior imaging and EMR. The radiologists' interpretation served as the ground truth, and determined if the AI-detected nodule was a true lung nodule and if further workup was required. RESULTS: A total of 683 patients met the inclusion criteria. The clinicians commented on 386 (56.5%) CXRs, identified true nodules on 113 CXRs (16.5%), incorrectly mentioned 31 (4.5%) false nodules as real nodules, and did not mention the AI detected nodule on 242 (35%) CXRs, of which 68 (10%) patients were retrospectively referred for further workup by the radiologist. For 297 patients (43.5%) there were no comments regarding the CXR in the EMR. Of these, 77 nodules (11.3%) were retrospectively referred for further workup by the radiologist. CONCLUSION: AI software for lung nodule detection may be insufficient without a formal radiology report, and may lead to over diagnosis or misdiagnosis of nodules.
Assuntos
Inteligência Artificial , Neoplasias Pulmonares , Adulto , Humanos , Estudos Retrospectivos , Neoplasias Pulmonares/diagnóstico por imagem , Radiografia Torácica/métodos , Interpretação de Imagem Radiográfica Assistida por Computador/métodos , Radiologistas , InteligênciaRESUMO
OBJECTIVES: To evaluate multi-parametric MRI for distinguishing stereotactic body radiation therapy (SBRT) induced pulmonary fibrosis from local recurrence (LR). MATERIALS AND METHODS: SBRT treated non-small cell lung cancer (NSCLC) patients suspected of LR by conventional imaging underwent MRI: T2 weighted, diffusion weighted imaging, dynamic contrast enhancement (DCE) with a 5-minute delayed sequence. MRI was reported as high or low suspicion of LR. Follow-up imaging ≥12 months or biopsy defined LR status as proven LR, no-LR or not-verified. RESULTS: MRI was performed between 10/2017 and 12/2021, at a median interval of 22.5 (interquartile range 10.5-32.75) months after SBRT. Of the 20 lesions in 18 patients: 4 had proven LR, 10 did not have LR and 6 were not verified for LR due to subsequent additional local and/or systemic therapy. MRI correctly identified as high suspicion LR in all proven LR lesions and low suspicion LR in all confirmed no-LR lesions. All proven LR lesions (4/4) showed heterogeneous enhancement and heterogeneous T2 signal, as compared to the proven no-LR lesions in which 7/10 had homogeneous enhancement and homogeneous T2 signal. DCE kinetic curves could not predict LR status. Although lower apparent diffusion coefficient (ADC) values were seen in proven LR lesions, no absolute cut-off ADC value could determine LR status. CONCLUSION: In this pilot study of NSCLC patients after SBRT, multi-parametric chest MRI was able to correctly determine LR status, with no single parameter being diagnostic by itself. Further studies are warranted.
Assuntos
Carcinoma Pulmonar de Células não Pequenas , Neoplasias Pulmonares , Radiocirurgia , Humanos , Carcinoma Pulmonar de Células não Pequenas/patologia , Neoplasias Pulmonares/patologia , Radiocirurgia/métodos , Estudos Prospectivos , Projetos Piloto , Recidiva Local de Neoplasia , Imageamento por Ressonância Magnética , Imagem de Difusão por Ressonância Magnética/métodos , Estudos RetrospectivosRESUMO
INTRODUCTION: The incidence of incisional hernias (IH) after midline laparotomy varies from 11% to 20%. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is potentially prone to hernias because a Xiphoid to pubis laparotomy incision performed on patients who have undergone previous abdominal surgeries with the addition of chemotherapy and its related adverse effects. METHODS: We performed a retrospective analysis on a prospectively maintained single institution database from March 2015 to July 2020. The inclusion criteria were patients who underwent CRS-HIPEC and had at least 6 months postoperative follow-up with post-operative cross-sectional imaging study. RESULTS: Two hundred and one patients were included in the study. All patients underwent CRS-HIPEC with resection of previous scar and umbilectomy. Fifty-four patients were diagnosed with IH (26.9%). The major risk factors for IH in multivariate analysis were higher American society of Anesthesiologists score (ASA) (OR 3.9, P = 0.012), increasing age (OR 1.06, P = 0.004) and increasing BMI (OR 1.1, P = 0.006). Most of the hernia sites were median (n = 43, 79.6%). Eleven (20.4%) patients had lateral hernias due to stoma incisions or drain sites. Most of the median hernias were at the level of the resected umbilicus 58.9% (n = 23). Five (9.3%) of the patients with IH necessitated an urgent surgical repair. CONCLUSION: We have demonstrated that more than a quarter of the patients after CRS-HIPEC suffer from IH and up to 10% of them may require surgical intervention. More research is needed to find the appropriate intraoperative interventions to minimize this sequela.